Monash University’s Precision Medicine research group has discovered multiple new genetic risk factors that make men susceptible to aggressive prostate cancer, in a landmark study [...]
Next month, MPCCC is introducing a new series of online talks presenting innovative and new technologies that are being applied to current cancer and clinical [...]
This May, Monash Partners Comprehensive Cancer Consortium (MPCCC) welcomed Felicity Topp, Chief Executive of Peninsula Health, to the role Governance Group Chair. Ms Topp’s extensive [...]
Delays in routine cancer care due to COVID19 have health professionals on high alert for a variety of service challenges predicted to arise in coming [...]
A new MPCCC partnership with Monash University’s Biomedicine Discovery Institute (Monash BDI) will investigate whether innovative research technologies, including multi-omic and organoid profiling, can improve the [...]
On 3 April 2020, MPCCC hosted its first online Precision Oncology Seminar, presented by health economics expert Professor Maarten IJzerman during which he presented his [...]
MPCCC has joined forces with the Victorian Comprehensive Cancer Centre (VCCC) alliance to help Victoria’s front line clinical teams adjust to managing cancer prevention, treatment [...]
Telehealth has become a vital tool for the care and safety of cancer patients during COVID-19 and has highlighted a variety of sustainable opportunities for [...]
Cancer patients will receive clear messaging and information about the importance and safety of their care during COVID-19 with the launch of the new Safe [...]
The MPCCC will recognise the achievements of innovative and impactful Victorian mid-career cancer researchers, with the presentation of its inaugural 2020 Award for Outstanding Cancer [...]
